Compounds having the formula (I), and pharmaceutically acceptable salts
thereof,
##STR1##
are useful for modulating mitochondrial F1F0 ATPase activity
and treating ischemic conditions including myocardial infarction, congestive heart
failure, and cardiac arrhythmias.